We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

80 hedge funds and large institutions have $90.2M invested in Gyre Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

424% more call options, than puts

Call options by funds: $398K | Put options by funds: $76K

72% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 18

59% more capital invested

Capital invested by funds: $56.5M → $90.2M (+$33.6M)

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

3% more funds holding

Funds holding: 78 → 80 (+2)

0.11% more ownership

Funds ownership: 8.52% → 8.63% (+0.11%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
80
Holders Change
+2
Holders Change %
+2.56%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
31
Reduced
18
Closed
15
Calls
$398K
Puts
$76K
Net Calls
+$322K
Net Calls Change
+$17K

Top Buyers

1
Verition Fund Management
Verition Fund Management
Connecticut
+$1.74M
2
OM
Opaleye Management
Massachusetts
+$859K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$803K
4
State Street
State Street
Massachusetts
+$555K
5
RJA
Raymond James & Associates
Florida
+$553K

Top Sellers

1
SCM
Stonepine Capital Management
Oregon
-$3.33M
2
Millennium Management
Millennium Management
New York
-$1.54M
3
PM
Prosight Management
Texas
-$1.3M
4
ACP
Acuta Capital Partners
California
-$811K
5
CCM
CAAS Capital Management
New York
-$670K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$529K +$183K +4,233 +61%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$506K +$9.79K +226 +2%
N
28
Nuveen
North Carolina
$505K +$17.6K +407 +4%
RJFSA
29
Raymond James Financial Services Advisors
Florida
$503K +$230K +5,306 +100%
EWM
30
Essex Woodlands Management
Texas
$496K – – –
JJIJ
31
Johnson & Johnson Innovation - JJDC
New Jersey
$422K – – –
Wells Fargo
32
Wells Fargo
California
$416K +$254K +5,873 +201%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$382K -$372K -8,586 -52%
Man Group
34
Man Group
United Kingdom
$373K +$30.6K +707 +10%
DC
35
Davenport & Co
Virginia
$373K +$341K +7,880 New
Russell Investments Group
36
Russell Investments Group
United Kingdom
$356K +$309K +7,129 +1,706%
Charles Schwab
37
Charles Schwab
California
$324K – – –
TAM
38
Tocqueville Asset Management
New York
$319K +$292K +6,744 New
Ameriprise
39
Ameriprise
Minnesota
$309K +$210K +4,860 +291%
Connor, Clark & Lunn Investment Management (CC&L)
40
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$287K +$8.05K +186 +3%
Citadel Advisors
41
Citadel Advisors
Florida
$280K +$77.3K +1,786 +43%
PPA
42
Parametric Portfolio Associates
Washington
$277K +$106K +2,443 +72%
CI Investments Inc
43
CI Investments Inc
Ontario, Canada
$258K +$235K +5,418 New
PP
44
PDT Partners
New York
$220K -$36.4K -841 -15%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$211K +$41.1K +949 +27%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$187K +$30K +692 +21%
Barclays
47
Barclays
United Kingdom
$183K -$17K -392 -9%
Bank of America
48
Bank of America
North Carolina
$171K -$433 -10 -0.3%
VAM
49
Verity Asset Management
North Carolina
$171K +$156K +3,606 New
AQR Capital Management
50
AQR Capital Management
Connecticut
$151K -$3.07K -71 -2%
1
2
3 4

GYRE Hedge Fund Activity: Q4 2020 in Review

80 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q4 2020, worth a combined $90.2M — up 59% from $56.5M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new GYRE positions and 15 closed out — a net gain of 3 holders — while 31 added to existing stakes and 18 trimmed.

The largest buyer was Verition Fund Management, opening a new position worth an estimated $1.74M. The largest seller was Stonepine Capital Management, cutting an estimated $3.33M.

  • 80 institutional investors held Gyre Therapeutics (GYRE) as of Q4 2020, up from 78 in Q3 2020.
  • Funds reported $90.2M of Gyre Therapeutics stock for Q4 2020, up 59% quarter-over-quarter.
  • 18 funds opened new Gyre Therapeutics positions in Q4 2020 and 15 closed out, a net change of +3 holders.
  • The largest Gyre Therapeutics buyer in Q4 2020 was Verition Fund Management, an estimated $1.74M added.
  • The largest Gyre Therapeutics seller in Q4 2020 was Stonepine Capital Management, an estimated $3.33M sold.

Based on aggregated 13F filings for Q4 2020.